A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin

By Roehrborn C.G.   Oesterling J.E.   Olson P.J.   Padley R.J.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 556-561

Elsevier

Access to resources Recommend Favorite

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia

By Hillman A.L.   Schwartz J.S.   Willian M.K.   Peskin E.   Roehrborn C.G.   Oesterling J.E.   Mason M.F.   Maurath C.J.   Deverka P.A.   Padley R.J.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 169-178

Elsevier

Access to resources Recommend Favorite

Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up

By Lam J.S.   Romas N.A.   Lowe F.C.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 354-358

Elsevier

Access to resources Recommend Favorite